![](/img/cover-not-exists.png)
PSS14 WHAT COST OF HLA-B*5801 GENOTYPING WOULD BE COST EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND: ANALYSES USING A DECISION-ANALYTIC MODEL
Somkrua, R, Chaiyakunapruk, N, Tassaneeyakul, WVolume:
13
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(11)73373-3
Date:
November, 2010
File:
PDF, 87 KB
english, 2010